Which glucose monitors were recalled and why?

A recall tied to serious outcomes has alarmed many with diabetes

A widely used model of continuous glucose sensor has been linked in reporting to multiple deaths and hundreds of injuries, prompting a large recall and renewed concern among people who depend on these devices to manage diabetes. The problem has been described as a manufacturing defect that affected the reliability of sensor readings in some units.

Millions of people rely on continuous glucose monitoring systems to guide insulin dosing and other daily decisions. When a sensor does not read accurately, it can produce falsely low or high values that lead users to underdose or overdose insulin, with potentially life‑threatening consequences. Public accounts and regulatory summaries associate the malfunction with at least seven deaths and hundreds of reported adverse events worldwide, which is what triggered the safety action and intensified communication from health authorities.

Practical steps for people using glucose monitors

• Check company and regulatory notices for whether your device or lot number is included in the recall.
• If you suspect inaccurate readings, confirm blood glucose with a fingerstick meter before changing insulin doses.
• Contact your diabetes care team or the device manufacturer immediately for guidance and replacement options.
• Report any device problems or health events to the food and drug safety agency in your country so regulators can collect needed data.

Why this matters

These devices are central to modern diabetes care, and a recall of this scale disrupts daily management for many patients. The incident highlights the importance of robust manufacturing quality controls, rapid reporting of device problems, and clear channels for patients and clinicians to get replacements and clinical advice when a monitoring system is withdrawn from the market.